Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dentistry
Volume 2013, Article ID 402096, 5 pages
http://dx.doi.org/10.1155/2013/402096
Case Report

Clinical Management of Suppurative Osteomyelitis, Bisphosphonate-Related Osteonecrosis, and Osteoradionecrosis: Report of Three Cases and Review of the Literature

1Department of Clinic and Surgery, School of Dentistry, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil
2Oral Pathology, College of Dental Medicine-Illinois, Midwestern University, Downers Grove, IL 60515, USA
3Oral Pathology, Department of Biomedical Sciences, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil
4Stomatology, Department of Clinic and Surgery, School of Dentistry, Federal University of Alfenas, 37130-000 Alfenas, MG, Brazil

Received 26 August 2013; Accepted 23 September 2013

Academic Editors: N. H. Rohleder and C.-H. Wu

Copyright © 2013 Eduardo Pereira Guimarães et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Baltensperger and G. Eyrich, Osteomyelitis of the Jaws, Springer, Berlin, Germany, 2008.
  2. S. C. Yeoh, S. MacMahon, and M. Schifter, “Chronic suppurative osteomyelitis of the mandible: case report,” Australian Dental Journal, vol. 50, no. 3, pp. 200–203, 2005. View at Google Scholar · View at Scopus
  3. J. J. Sciubba and D. Goldenberg, “Oral complications of radiotherapy,” The Lancet Oncology, vol. 7, no. 2, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Teng and N. D. Futran, “Osteoradionecrosis of the mandible,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 13, no. 4, pp. 217–221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Ruggiero, “Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 13–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Migliorati, S. B. Woo, I. Hewson et al., “A systematic review of bisphosphonate osteonecrosis (BON) in cancer,” Supportive Care in Cancer, vol. 18, no. 8, pp. 1099–1106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Marx and R. Tursun, “Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease,” International Journal of Oral and Maxillofacial Surgery, vol. 41, no. 3, pp. 283–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Fullmer, W. C. Scarfe, G. M. Kushner, B. Alpert, and A. G. Farman, “Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible,” British Journal of Oral and Maxillofacial Surgery, vol. 45, no. 5, pp. 364–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. F. Koorbusch, P. Fotos, and K. T. Goll, “Retrospective assessment of osteomyelitis. Etiology, demographics, risk factors, and management in 35 cases,” Oral Surgery Oral Medicine and Oral Pathology, vol. 74, no. 2, pp. 149–154, 1992. View at Google Scholar · View at Scopus
  10. C. R. Bevin, C. Y. Inwards, and E. E. Keller, “Surgical management of primary chronic osteomyelitis: a long-term retrospective analysis,” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 10, pp. 2073–2085, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Frid, K. Tornes, Ø. Nielsen, and N. Skaug, “Primary chronic osteomyelitis of the jaw—a microbial investigation using cultivation and DNA analysis: a pilot study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 5, pp. 641–647, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Coviello and M. R. Stevens, “Contemporary concepts in the treatment of chronic osteomyelitis,” Oral and Maxillofacial Surgery Clinics of North America, vol. 19, no. 4, pp. 523–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. E. Marx, “Chronic osteomyelitis of the jaws,” in Oral and Maxillofacial Surgery Clinics of North America, D. Laskin and R. Strass, Eds., pp. 367–438, Saunders, Philadelphia, Pa, USA, 1992. View at Google Scholar
  14. L. G. Mercuri, “Acute osteomyelitis of the jaws,” Oral and Maxillofacial Surgery Clinics of North America, vol. 3, no. 2, p. 355, 1991. View at Google Scholar
  15. B. A. Jereczek-Fossa and R. Orecchia, “Radiotherapy-induced mandibular bone complications,” Cancer Treatment Reviews, vol. 28, no. 1, pp. 65–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Reuther, T. Schuster, U. Mende, and A. C. Kübler, “Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 3, pp. 289–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Ben-David, M. Diamante, J. D. Radawski et al., “Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions,” International Journal of Radiation Oncology, Biology and Physics, vol. 68, no. 2, pp. 396–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. American Association of Oral and Maxillofacial Surgeons, “Position paper on bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 3, pp. 369–376, 2007. View at Publisher · View at Google Scholar
  19. S. R. Nussbaum, J. Younger, C. J. Vandepol et al., “Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages,” American Journal of Medicine, vol. 95, no. 3, pp. 297–304, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. E. R. Carlson and J. D. Basile, “The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 85–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Migliorati, J. Casiglia, J. Epstein, P. L. Jacobsem, M. A. Siegel, and S. B. Woo, “Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper,” Journal of the American Dental Association, vol. 136, no. 12, pp. 1658–1668, 2005. View at Google Scholar · View at Scopus
  22. R. E. Marx, “Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 9, pp. 1115–1117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ruggiero, J. Gralow, R. E. Marx et al., “Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer,” Journal of Oncology Practice, vol. 2, no. 1, pp. 7–14, 2006. View at Publisher · View at Google Scholar
  24. L. M. Hess, J. M. Jeter, M. Benham-Hutchins, and D. S. Alberts, “Factors associated with osteonecrosis of the jaw among bisphosphonate users,” The American Journal of Medicine, vol. 121, no. 6, pp. 475.e3–483.e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Silvestre-Rangil and F.-J. Silvestre, “Clinico-therapeutic management of osteoradionecrosis: a literature review and update,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 16, no. 7, pp. e900–e904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Theologie-Lygidakis, O. Schoinohoriti, and I. Iatrou, “Surgical management of primary chronic osteomyelitis of the jaws in children: a prospective analysis of five cases and review of the literature,” Oral and Maxillofacial Surgery, vol. 15, no. 1, pp. 41–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Freiberger, “Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, supplement, pp. 96–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Erkan, O. Bilgi, M. Mutluoğlu, and G. Uzun, “Biphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy,” Journal of the Pancreas, vol. 10, no. 5, pp. 579–580, 2009. View at Google Scholar · View at Scopus
  29. K. Shimura, C. Shimazaki, K. Taniguchi et al., “Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma,” International Journal of Hematology, vol. 84, no. 4, pp. 343–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Curi, G. Saraceni Issa Cossolin, D. H. Koga et al., “Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 2, pp. 349–355, 2007. View at Publisher · View at Google Scholar · View at Scopus